Transforming America’s Force Projection Capability: STRATEGIC PARTNER INTEGRATION REQUIRED von Fasching, John

Volltext

Transforming America's Force Projection Capability von Fasching, John

Volltext

Continual Transformation at the chapter level: underway revitalization while transforming and at war von Fasching, John

Volltext

CHAPTER REPORT: Central Pennsylvania von Fasching, John

Volltext

round up: CHAPTER RESOLUTIONS von Fasching, John, Young, Richard

Volltext

Chapter resolutions; Central Pennsylvania Chapter kicks off holiday season by honoring veterans' selfless service von Fasching, John, Young, Richard

Volltext

CHAPTER RESOLUTIONS von Fasching, John, Young, Richard

Volltext

Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis von Huang, Min, O'Shaughnessy, Joyce, Zhao, Jing, Haiderali, Amin, Cortés, Javier, Ramsey, Scott D, Briggs, Andrew, Hu, Peter, Karantza, Vassiliki, Aktan, Gursel, Qi, Cynthia Z, Gu, Chenyang, Xie, Jipan, Yuan, Muhan, Cook, John, Untch, Michael, Schmid, Peter, Fasching, Peter A

Volltext

The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis von Ooi, Brandon Nick Sern, Loh, Huiwen, Ho, Peh Joo, Milne, Roger L, Giles, Graham, Gao, Chi, Kraft, Peter, John, Esther M, Swerdlow, Anthony, Brenner, Hermann, Wu, Anna H, Haiman, Christopher, Evans, D Gareth, Zheng, Wei, Fasching, Peter A, Castelao, Jose Esteban, Kwong, Ava, Shen, Xia, Czene, Kamila, Hall, Per, Dunning, Alison, Easton, Douglas, Hartman, Mikael, Li, Jingmei

Volltext

Ribociclib plus Endocrine Therapy in Early Breast Cancer von Slamon, Dennis, Lipatov, Oleg, Nowecki, Zbigniew, McAndrew, Nicholas, Kukielka-Budny, Bozena, Stroyakovskiy, Daniil, Yardley, Denise A., Huang, Chiun-Sheng, Fasching, Peter A., Crown, John, Bardia, Aditya, Chia, Stephen, Im, Seock-Ah, Ruiz-Borrego, Manuel, Loi, Sherene, Xu, Binghe, Hurvitz, Sara, Barrios, Carlos, Untch, Michael, Moroose, Rebecca, Visco, Frances, Afenjar, Karen, Fresco, Rodrigo, Severin, Irene, Ji, Yan, Ghaznawi, Farhat, Li, Zheng, Zarate, Juan P., Chakravartty, Arunava, Taran, Tetiana, Hortobagyi, Gabriel

Volltext

NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto von Untch, Michael, Jackisch, Christian, Schneeweiss, Andreas, Schmatloch, Sabine, Aktas, Bahriye, Denkert, Carsten, Schem, Christian, Wiebringhaus, Hermann, Kümmel, Sherko, Warm, Mathias, Fasching, Peter A, Just, Marianne, Hanusch, Claus, Hackmann, John, Blohmer, Jens-Uwe, Rhiem, Kerstin, Schmitt, Wolfgang D, Furlanetto, Jenny, Gerber, Bernd, Huober, Jens, Nekljudova, Valentina, von Minckwitz, Gunter, Loibl, Sibylle

Volltext

Phase III Trial of Sunitinib in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Patients With Pretreated Metastatic Breast Cancer von CROWN, John P, DIERAS, Véronique, GREIL, Richard, COGNETTI, Francesco, FOUNTZILAS, George, BLASINSKA-MORAWIEC, Maria, LIEDTKE, Cornelia, KREIENBERG, Rolf, MILLER, Wilson H, TASSELL, Vanessa, XIN HUANG, PAOLINI, Jolanda, STAROSLAWSKA, Elzbieta, KERN, Kenneth A, ROMIEU, Gilles, YARDLEY, Denise A, BACHELOT, Thomas, DAVIDSON, Neville, WILDIERS, Hans, FASCHING, Peter A, CAPITAIN, Olivier, RAMOS, Manuel

Volltext

Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women von Kadalayil, Latha, Khan, Sofia, Nevanlinna, Heli, Fasching, Peter A., Couch, Fergus J., Hopper, John L., Liu, Jianjun, Maishman, Tom, Durcan, Lorraine, Gerty, Sue, Blomqvist, Carl, Rack, Brigitte, Janni, Wolfgang, Collins, Andrew, Eccles, Diana, Tapper, William

Volltext

A careful reassessment of anthracycline use in curable breast cancer von Hurvitz, Sara Alsterlind, McAndrew, Nicholas P., Bardia, Aditya, Press, Michael F., Pegram, Mark, Crown, John P., Fasching, Peter A., Ejlertsen, Bent, Yang, Eric H., Glaspy, John A., Slamon, Dennis J.

Volltext

Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials von Villegas, Sonia L., Nekljudova, Valentina, Pfarr, Nicole, Engel, Jutta, Untch, Michael, Schrodi, Simone, Holms, Frank, Ulmer, Hans U., Fasching, Peter A., Weber, Karsten E., Albig, Christian, Heinrichs, Clemens, Marmé, Frederik, Hartmann, Arndt, Hanusch, Claus, Schmitt, Wolfgang D., Huober, Jens, Lederer, Bianca, van Mackelenbergh, Marion, Tesch, Hans, Jackisch, Christian, Rezai, Mahdi, Sinn, Peter, Sinn, Bruno V., Hackmann, John, Kiechle, Marion, Schneeweiss, Andreas, Weichert, Wilko, Denkert, Carsten, Loibl, Sibylle

Volltext

A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diag... von Robertson, John F R, Evans, Abigail, Henschen, Stephan, Kirwan, Cliona C, Jahan, Ali, Kenny, Laura M, Dixon, J Michael, Schmid, Peter, Kothari, Ashutosh, Mohamed, Omar, Fasching, Peter A, Cheung, Kwok-Leung, Wuerstlein, Rachel, Carroll, Danielle, Klinowska, Teresa, Lindemann, Justin P O, MacDonald, Alexander, Mather, Richard, Maudsley, Rhiannon, Moschetta, Michele, Nikolaou, Myria, Roudier, Martine P, Sarvotham, Tinnu, Schiavon, Gaia, Zhou, Diansong, Zhou, Li, Harbeck, Nadia

Volltext

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome von Pfeffer, Marc A, Claggett, Brian, Diaz, Rafael, Dickstein, Kenneth, Gerstein, Hertzel C, Køber, Lars V, Lawson, Francesca C, Ping, Lin, Wei, Xiaodan, Lewis, Eldrin F, Maggioni, Aldo P, McMurray, John J.V, Probstfield, Jeffrey L, Riddle, Matthew C, Solomon, Scott D, Tardif, Jean-Claude

Volltext

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism von Raskob, Gary E, van Es, Nick, Verhamme, Peter, Carrier, Marc, Di Nisio, Marcello, Garcia, David, Grosso, Michael A, Kakkar, Ajay K, Kovacs, Michael J, Mercuri, Michele F, Meyer, Guy, Segers, Annelise, Shi, Minggao, Wang, Tzu-Fei, Yeo, Erik, Zhang, George, Zwicker, Jeffrey I, Weitz, Jeffrey I, Büller, Harry R

Volltext

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer von Ross, L., Eisen, A., Elsafy, F., Fielding, A., Friedman, S., Gianni, L., Phillips, K.-A., Singer, C.F., Toi, M., Park, Y.H., Yang, H., Mailliez, A., Nagy, T., Sonke, G.S., Sun, Q., Colleoni, M.A., Kaufman, B., Cameron, D., Campbell, C., Sevelda, Paul, Öhler, Leopold, Rumpold, Holger, Rautenberg, Beate, Boadle, David, Mackey, John, Niraula, Saroj, Randal d’Hondt, Papadimitriou, Konstantinos, Lazzaro, Mauricio Fernández, Pilnik, Norma, Varela, Mirta, Darsow, Maren, Park-Simon, Tjoung-Won, Terhaag, Jürgen, Salat, Christoph, Dieterich, Max, García Sáenz, José Ángel, Lanza, Angels Arcusa, Quiroga, Vanesa, Jañez, Noelia Martínez, Crusades, Gema Llort, Rodríguez, César, Cretella, Elisabetta, Jegannathen, Apurna, Ishida, Kazushige, Watanabe, Junichiro, Takada, Masahiro, Nakamura, Seigo, Aogi, Kenjiro, Tsugawa, Koichiro, Seaward, Samantha A., Carney, Jennifer Fu, Bobolis, Kristie A., Eisenberg, Peter D., Hofstatter, Erin W., McCarron, Edward C., Herbolsheimer, Pia, Meisel, Jane L., Jones, Cheryl F., Spector, David M., Lo, Shelly S., Cristofanilli, Massimo, Hahn, Olwen M., Oliff, Ira A., Ansari, Bilal, Sharma, Priyanka, Armstrong, Deborah K., VanderWoude, Amy, Friday, Bret E.B., T, Benjamin, Kuzma, Charles S., Radford, James E., Soori, Gamini S., Vogel, Victor G., Wilkinson, Mary, Qamar, Rubina, Loman, Niklas, Silander, Gustav, Abreu, Miguel, Ciruelos Gil, Eva María, Bermejo de las Heras, Begoña, Busch, Steffi, Thomalla, Jörg, Altena, Renske, Chen, Shou-Tung, Huang, Chiun-Sheng, Yeh, Dah-Cherng, Pottier, Virginie, Yang, Hongjian, Fu, Peifen, Wang, Yongsheng, Fan, Zhimin, Landherr, László, Yerushalmi, Rinat, Conte, Pierfranco, Ciccarese, Mariangela, Mackiewicz, Jacek, Kalinka, Ewa, Im, Seock-Ah, Lee, Kyoung Eun

Volltext

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer... von Slamon, Dennis J., Fasching, Peter A., Hurvitz, Sara, Chia, Stephen, Crown, John, Martín, Miguel, Barrios, Carlos H., Bardia, Aditya, Im, Seock-Ah, Yardley, Denise A., Untch, Michael, Huang, Chiun-Sheng, Stroyakovskiy, Daniil, Xu, Binghe, Moroose, Rebecca L., Loi, Sherene, Visco, Frances, Bee-Munteanu, Valerie, Afenjar, Karen, Fresco, Rodrigo, Taran, Tetiana, Chakravartty, Arunava, Zarate, Juan Pablo, Lteif, Agnes, Hortobagyi, Gabriel N.

Volltext